All products
Weight Management
Tirzepatide
Once-weekly dual agonist therapy for significant weight loss
Overview
A once-weekly injectable GLP-1/GIP receptor agonist that supports significant weight loss by targeting two key hormones involved in appetite and metabolism.
Key highlights
- Once-weekly subcutaneous injection
- Dual GLP-1 and GIP receptor activation
- Reduces appetite and slows digestion
- Supports sustainable weight loss
- Improves blood sugar control
Indications
- Chronic weight management
- Adults with obesity or overweight with comorbidities
- Type 2 diabetes adjunct
Pricing
| Mounjaro 2.5 mg | ₦600,000 |
| Mounjaro 5 mg | ₦700,000 |
| Mounjaro 7.5 mg | ₦800,000 |
| Mounjaro 10 mg | ₦900,000 |
| Mounjaro 12.5 mg | ₦950,000 |
| Mounjaro 15 mg | ₦1,000,000 |
Prices in Nigerian Naira (₦) and subject to change. Contact us to confirm availability.
This product page is intended for informational purposes. Full prescribing information is available to licensed healthcare professionals on request.